Home > Food & Beverages > Nutraceuticals > Omega 3 > Infant Formula DHA Algae Oil Market

Infant Formula DHA Algae Oil Market Analysis

  • Report ID: GMI4832
  • Published Date: Nov 2023
  • Report Format: PDF

Infant Formula DHA Algae Oil Market Analysis

The 40%-50% DHA content segment will experience robust growth, surpassing 7.5% CAGR through 2032, due to its role in enhancing infant cognitive development and its natural, sustainable sourcing.
 

  • Numerous clinical studies and research have demonstrated that a higher concentration of infant formula DHA algae oil contributes to improved brain and visual development. As parents and healthcare professionals increasingly prioritize the long-term cognitive health of infants, the product demand will rise.
     
  • The rise in environmental awareness and sustainability concerns has pushed consumers and manufacturers towards more eco-friendly alternatives. Algae-derived DHA with a 40-50% content offers a sustainable solution as it doesn't rely on traditional fish oil sources, which can deplete marine resources.
     

a DHA algae oil market for the 0-3 years age group segment is projected to sustain strong growth until 2032, attributed to a substantial increase in birth rates and the recommendations from health organizations emphasizing the importance of sufficient omega-3 fatty acids intake during early childhood.
 

  • The product plays a pivotal role in various physiological and cellular processes crucial for infant development. It's particularly recommended for nursing infants or toddlers when maternal omega-3 levels have not been assessed to ensure their adequate nutritional needs are met.
     
  • During the infant years, babies typically require a daily intake of 500-800 mg of docosahexaenoic acid (DHA) to facilitate healthy growth and support critical transformations, including promotion of cognitive health, fortification of the immune system, enhanced metabolism, and overall normal development.
     

North America infant formula DHA algae oil market is poised for steady growth with over 3.5% CAGR till 2032, owing to a strong demand for DHA-fortified supplements and functional foods. The region's health-conscious consumer base has a preference for sustainable and plant-based sources of omega-3, such as DHA algae oil. Additionally, the presence of numerous key players and manufacturers specializing in DHA algae oil products in North America has led to a wide range of innovative formulations and applications. This factor, alongside the regulatory support and stringent quality standards in the region have resulted in innovation trends and product credibility, pushing the regional market expansion.

Authors: Kunal Ahuja, Sarita Bayas

Frequently Asked Questions (FAQ) :

The market size of infant formula DHA algae oil is poised to witness 8.5 % CAGR through 2032, backed by the increasing awareness of the health benefits associated with DHA.

The 40%-50% DHA content segment will experience robust growth, surpassing 7.5% CAGR during 2023-2032, due to its role in enhancing infant cognitive development and its natural, sustainable sourcing.

North America market is set for steady growth with over 3.5% CAGR through 2032, owing to a strong demand for DHA-fortified supplements and functional foods.

Algisys, Archer Daniel Midland Company, Corbion, Koninklijke DSM N.V., Lonza Group, Cellana, Polaris SA, and Qualitas Health.

Infant Formula DHA Algae Oil Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 20
  • Tables & Figures: 198
  • Countries covered: 22
  • Pages: 200
 Download Free Sample